Endothelial Cell Activation and Total Pulmonary Resistance in PAH

Repeatability and Sensitivity to Change of Non-invasive Endpoints in PAH

NCT03841344 ·Status: UNKNOWN ·Phase: NA

The Role of Endothelin in Pulmonary Hypertension

NCT00759408 ·Status: COMPLETED ·Phase: PHASE2

Effect of Endothelin-1 Receptor Blockade on Circulating Endothelial Microparticles Levels in Patients With Pulmonary Hypertension

NCT00675051 ·Status: COMPLETED

Dose Determination Safety and Activity Study of Inhaled NX1011 to Treat Pulmonary Arterial Hypertension

NCT00323024 ·Status: WITHDRAWN ·Phase: PHASE2

Oxygen Treatment and Pulmonary Arterial Hypertension

NCT03683082 ·Status: UNKNOWN ·Phase: NA

Effect of Inhaled Albuterol in Pulmonary Hypertension

NCT03270332 ·Status: COMPLETED ·Phase: PHASE2

Study of ACT-293987 (NS-304) in Pulmonary Arterial Hypertension (PAH)

NCT00993408 ·Status: COMPLETED ·Phase: PHASE2

129 Xenon Imaging in Patients Treated With Sotatercept

NCT06351345 ·Status: RECRUITING ·Phase: PHASE2

Efficacy and Safety of Triple-targeted Drug Therapy in Treatment-naive Patients With Non-low-risk PAH: A Real-world, Multicenter Study

NCT06753981 ·Status: RECRUITING

Responsiveness of Exercise Tests in Pulmonary Arterial Hypertension

NCT01391104 ·Status: COMPLETED ·Phase: NA

National Registry and Cohort Study of Pulmonary Vascular Disease

NCT05368467 ·Status: RECRUITING

Haemodynamic Effects of Apelin Agonists and Antagonists in Man in COPD With Raised Pulmonary Artery Pressures

NCT02129309 ·Status: COMPLETED ·Phase: NA

Discovering Clinical Study Experiences of Patients With Pulmonary Hypertension

NCT05918458 ·Status: NOT_YET_RECRUITING

Retrospective Data Analysis of Data From the Zurich PH Registry

NCT03198910 ·Status: COMPLETED

A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489

NCT07073820 ·Status: RECRUITING ·Phase: PHASE2

Hormonal, Metabolic, and Signaling Interactions in PAH

NCT01884051 ·Status: RECRUITING

A Study of Real-world Cohort of Pulmonary Arterial Hypertension (PAH) Participants

NCT04955990 ·Status: TERMINATED ·Phase: PHASE4

Transforming Growth Factor Beta Signalling in the Development of Muscle Weakness in Pulmonary Arterial Hypertension

NCT01847716 ·Status: TERMINATED

Patient Global Impression Questions for Activity-Induced Symptoms in Participants With PAH

NCT03888365 ·Status: COMPLETED

Efficacy and Safety of Bosentan in Sickle Cell Disease (SCD) Patients With Pulmonary Arterial Hypertension (PAH)

NCT00310830 ·Status: TERMINATED ·Phase: PHASE3

Apabetalone for Pulmonary Arterial Hypertension: a Pilot Study

NCT03655704 ·Status: COMPLETED ·Phase: EARLY_PHASE1

A Therapeutic Open Label Study of Tocilizumab in the Treatment of Pulmonary Arterial Hypertension

NCT02676947 ·Status: COMPLETED ·Phase: PHASE2

Pulmonary Hypertension on Prognosis of Acute Myocardial Infarction Patients With Reduced Left Ventricular Function

NCT06186713 ·Status: COMPLETED

Open-label, Multi-center Protocol to Provide QTI571 to PAH Patients Who Participated in the Extension Study (A2301E1) in Japan

NCT02042014 ·Status: COMPLETED ·Phase: PHASE3

A Dose-escalation Study in Subjects With Pulmonary Arterial Hypertension (PAH)

NCT03177603 ·Status: COMPLETED ·Phase: PHASE2